Sunshine Biopharma (SBFM) Net Margin (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Net Margin came in at 15.38% in Q1 2026, down 212.0% YoY from 13.73% in Q1 2025, and up 38.39% on a QoQ basis from 24.96% in Q4 2025.
Sunshine Biopharma (SBFM) Net Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Net Margin data on file, last reported at 15.38% in Q1 2026.
- Quarterly Net Margin fell 212.0% year-over-year to 15.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.02% (up 41.0% YoY) and the FY2025 annual result came in at 16.46%, down 174.0% from the prior year.
- Net Margin climbed to 15.38% in Q1 2026, from 24.96% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 3.14% in Q3 2025 to a low of 1097.09% in Q3 2022.
- A 5-year average of 193.69% and a median of 19.11% in 2024 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 1443245 bps in 2022, down 138054 bps in 2022.
- Tracing SBFM's Net Margin over 5 years: stood at 596.78% in 2022, then surged by 97 bps to 15.78% in 2023, then tumbled by 43 bps to 22.49% in 2024, then fell by 11 bps to 24.96% in 2025, then jumped by 38 bps to 15.38% in 2026.
- The last three Net Margin figures came in at 15.38% (Q1 2026), 24.96% (Q4 2025), and 3.14% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -16.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.88% |
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | -24.96% |
| Sep 30, 2025 | 3.14% |
| Jun 30, 2025 | -31.36% |
| Mar 31, 2025 | -13.25% |
| Dec 31, 2024 | -22.49% |
| Sep 30, 2024 | -14.20% |
| Jun 30, 2024 | -19.11% |
| Mar 31, 2024 | -17.02% |
| Dec 31, 2023 | -15.78% |
| Sep 30, 2023 | -10.94% |
| Jun 30, 2023 | -16.22% |
| Mar 31, 2023 | -34.79% |
| Dec 31, 2022 | -596.78% |
| Sep 30, 2022 | -1,097.09% |
| Jun 30, 2022 | -358.51% |
| Mar 31, 2022 | -1,007.98% |
| Dec 31, 2021 | 783.75% |
| Sep 30, 2021 | -8,018.47% |